Newer Alkylating Agents for Brain Tumor Treatment
Alkylating agents are a type of chemotherapy drug used to treat cancer. They work by damaging the DNA of cancer cells, preventing them from growing and dividing. Recently, newer alkylating agents have been developed that can be used to treat brain tumors.
Temozolomide
Temozolomide is one of the most commonly used alkylating agents for treating brain tumors. It is taken orally in pill form and works by interfering with the growth and division of cancer cells. Studies have shown that temozolomide can be effective in treating both low-grade and high-grade gliomas, as well as other types of brain tumors.
Lomustine
Lomustine is another alkylating agent that has been used to treat brain tumors. It is usually given intravenously and works by damaging the DNA of cancer cells, preventing them from growing and dividing. Lomustine has been found to be effective in treating certain types of brain tumors, including glioblastoma multiforme.
Carmustine
Carmustine is an alkylating agent that has also been used to treat brain tumors. It is usually given intravenously and works by damaging the DNA of cancer cells, preventing them from growing and dividing. Carmustine has been found to be effective in treating certain types of brain tumors, including glioblastoma multiforme.